Get started
Renaissance IPO ETFRenaissance IPO ETFRenaissance IPO ETF

Renaissance IPO ETF

No trades
See on Supercharts
Overview Analysis Holdings News
Ideas
Discussions Technicals Seasonals Options

IPO trade ideas

Deal 115 - IPO 4 Therapeutics (CCCC) -money for cancer treatmentStock market. Stocks. IPO of C4 Therapeutics (CCC) — October 02, 2020 will start trading on the US NASDAQ stock exchange for the company that develops new cancer treatments by using the natural regulation of protein in the body. The placement is underwritten by Jefferies, Evercore ISI, BMO Capital Markets and UBS Investment Bank. The deadline for submitting an application with the broker is 20-00 Moscow time 30.09.2020, the placement date is 01.10.2020. 2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to receive them is asked to write with private messages.
AMEX:IPOLong
by ivan_gold_star_
🌀 Deal ✓102 - DPO Palantir Technologies (PLTR) - make money?DPO Palantir Technologies (PLTR) - developer OF US intelligence software will make money? Stock market. Stocks. DPO Palantir Technologies (PLTR) — Palantir Technologies will be directly listed on the NYSE on September 30. The company was founded in 2003 and started as a developer of software for US intelligence. 2% of the Fund will be invested in shares of this company, we will buy on the market at the opening of trading. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)
AMEX:IPOLong
by ivan_gold_star_
Deal #101 - IPO Pulmonx Corp (LANG) -make money on the treatmentStock market. Stocks. IPO Pulmonx Corp (LUNG) — on October 01, 2020, trading in shares of the company that developed the Zephyr technology will begin on the American stock exchange (the deadline for submitting an application for participation with a broker is 20-00 Moscow time on 29.09.2020). A special device is placed in the airway to treat severe emphysema. The placement is underwritten by BofA Securities and Morgan Stanley. 2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)
AMEX:IPOLong
by ivan_gold_star_
📊 Statistics are an interesting thing! Results of publishedStatistics are an interesting business! Thanks to it, you can determine the indicators of your work and understand how much this work could bring! We openly publish some of our deals online before the event starts and tell you how much we bet and why. Today we will show you the equity of current positions and how much you could earn by using our "tips" and our work copying all trades. We also want to note that these are not all transactions that were carried out by the Fund, since we conduct some profitable operations online and it is not possible to have time to publish posts in all networks, so we will highlight the published articles. Yellow indicates positions that are still in the market or have not yet been completed. As you can see, we usually put 2% of the Fund and we have 5 losing trades and 14 plus ones. If you calculate that about 1 million rubles were invested in the Fund, and bets were placed on all events, then you could earn +3.64% or +36400 rubles! Question — how much have you helped earn over the past 2 months by publishing your trading ideas on various exchanges in advance?
AMEX:IPO
by ivan_gold_star_
🌀 Attention! Deal °86 IPO Prelude T. - for cancer treatment!Stock market. Stocks. IPO Prelude Therapeutics — (PRLD) - September 25, 2020 on the American stock exchange will begin trading shares of the company (the deadline for submitting an application for participation with a broker is 20-00 Moscow time on 23.09.2020), which develops drugs for the treatment of cancer. The placement is underwritten by Morgan Stanley, Goldman Sachs and Bofasecuries. Company: Prelude Therapeutics (PLC) is a boutique Rating: 3 stars out scoop: 2 Oversubscription: 100% Allocation: up to 20% 2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)
AMEX:IPOLong
by ivan_gold_star_
🌀 Attention! Deal °85-IPO of Taisha Gene Therapy (THE) biotechsStock market. Stocks. IPO Taysha Gene Therapies — TSHA) - September 24, 2020 on the American stock exchange will begin trading shares of the company (the deadline for submitting an application for participation with a broker is 14-00 Moscow time on 23.09.2020), which specializes in the development of methods for treating the Central nervous system through gene therapy. The placement is underwritten by Goldman Sachs, Morgan Stanley and Jefferies. Boutique rating:3 scoop Rating: 2 Oversubscription: 200% Allocation: up to 50% 2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF in the Fund (additional data on request in PM)
AMEX:IPOLong
by ivan_gold_star_
IPOs - HOT HOT HOT!!Is it feeling frothy or what? IPO ETF at all time highs. Market is hot hot hot and nary a bear anywhere. Just not sure what to think at this point. I'm finding myself buying stocks that I never buy for FOMO. Hedged completely just in cast but wow when I see a chart like this and look a the underlying hot IPOs, 2020 has seen many of them up 50% or more. Getting awfully hot in the kitchen but this thing still may have room to run to the 39s based on impulse leg outlined.
AMEX:IPO
by BobbySpa